Congo begins trial of Gilead’s experimental antiviral for Ebola Bundibugyo
July 14 (Reuters) - Researchers in the Democratic Republic of Congo said on Tuesday they have started enrolling participants in a trial testing Gilead...
Read the full articleYou might also wanna read
Congo begins trial of Gilead's experimental antiviral for Ebola Bundibugyo
The outbreak has led to 1,963 confirmed cases in Congo
Experimental treatment trial for Ebola patients begins in Congo
The Democratic Republic of the Congo (DRC) has begun a groundbreaking clinical trial to test two experimental drugs for treating Ebola.
Trial of potential Ebola antiviral under way — WHO
GENEVA, Switzerland — The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strai
Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola
Clinical trials for treatments targeting the Bundibugyo strain of the Ebola virus disease began on July 2 in the Democratic Republic of Cong
Clinical trials begin in DRC epicenter of Bundibugyo strain of Ebola
Clinical trials for treatments targeting the Bundibugyo strain of the Ebola virus disease began on July 2 in the Democratic Republic of Cong
Trial of potential Ebola antiviral under way, says WHO
The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola strain spreading in the Dem
Residents in eastern Congo cling to hope as a new Ebola treatment trial begins
Residents in Congo's Ebola outbreak zone are hopeful as researchers begin a study of two potential treatments
Comments
Sign in to join the conversation.
No comments yet. Be the first.